EXPLORE

Discover the latest medical research and breakthroughs

CONNECT

Engage with a community of medical professionals and researchers

CONTRIBUTE

Share your insights and help advance medical knowledge

How Nongenetic Code-Based NTinti RNA Enzyme Distinguishes Superfluous Genetic Code-Based RNA from Normal RNA, Degrading the Former and Sparing the Latter
Published: September 4. 2026 Journals
Primary, secondary, and tertiary structures: Properties of macromolecular nongenetic code-based RNA enzyme synthesized by redox cycle NADH-glutamate dehydrogenase.
Published: June 10. 2026 Journals
Human Astrocyte NADH-Glutamate Dehydrogenase-Produced Macromolecular Nongenetic Code-Based RNA Enzymes for Treating and Curing Drug Addiction.
Published: April 10. 2026 Journals
Development of astrocyte NADH-glutamate dehydrogenase-synthesized macromolecular RNA enzymes for the prevention and treatment of opioid addiction
Published: February 2. 2026 Journals
Selective Apoptosis and Residual Longevity of Human Astrocytes Treated with 25 mM Gabapentin
Published: August 29. 2025 Journals
The Effect of Gabapentin on Human Astrocyte Cell Growth and Development: Implications for Clinical Use
Published: March 21. 2025 Journals
New Treatment for Alzheimer’s Dementia and Parkinson’s Disease Ready for Clinical Trial; The Chimerenomic RNA Enzyme.
Published: February 21. 2025 Journals
Transformation from Growth to Aging in Human Astrocytes Cell Cultures: The Role of NADH-Glutamate Dehydrgenase Isoenzyme.
Published: December 2. 2024 Journals
Environment-wide reprogramming of total RNA abundance and metabolic processes by Glutamate dehydrogenase-synthesized RNA enzyme: Terminologies for the New RNAs.
Published: November 21. 2024 Journals
The Chimerenomic Pump: Large-Scale Production of Glutamate Dehydrogenase-Synthesized RNAs.
Published: November 21. 2024 Journals
American Academy of Primary Care Research

Chimerenomic macromolecular RNA is the largest

active man-made molecule in the world

Godson Osuji and Remigius Okea are pioneering research scientists who have developed the largest known series of active biological molecules. These remarkable molecules, referred to as chimerenomic RNA, are unique macromolecular RNA that are produced independent of the genetic code. Each chimerenomic macromolecular RNA, also called NTinti, typically comprises 10.5 billion nucleotide bases (see references 1, 2, 3), and has a mass of approximately 3.57 x 10^12 Daltons, making it 1.7 times larger and longer than the human genome, which consists of 3.2 billion base pairs and weighs 2.04 x 10^12 Daltons. Indeed, chimerenomic macromolecular RNA is the largest active man-made molecule in the world.

These biologically active chimerenomic NTinti RNAs have proven invaluable across various fields, including biology, molecular chemistry, and medicine, leading to the emergence of new disciplines known as chimerenomic sciences. This innovative field is paving the way for the invention of breakthroughs because of the new understanding of previously inexplicable phenomena in science and medicine. Osuji and Okea have aptly dubbed these biologically active extra-large RNA molecules the "molecule of new life”

  1. Osuji GO, Okea RN (2024). Environment-wide reprogramming of total RNA abundance and metabolic processes by glutamate dehydrogenase-synthesized RNA enzyme: Terminologies for the new RNAs. JAAPCR Vol. 1, issue 1.
  2. Okea RN, Osuji GO (2024). Transformation from growth to aging in human astrocyte cell cultures: The role of NADH-glutamate dehydrogenase isoenzymes. JAAPCR Vol. 1, issue 3.
  3. Okea RN, Osuji GO (2025). New Treatment for Alzheimer’s Dementia and Parkinson’s Disease Ready for Clinical Trial; The Chimerenomic RNA Enzyme. JAAPCR Vol. 2, issue 2.

Popular Manuscripts View all

Our community speaks

Insights and experiences from the medical community
Browse by publication
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
American Academy of Primary Care Research